新药杂质评估03-Evaluating Impurities in Drugs 03.docVIP

Evaluating Impurities in Drugs (Part III of III) In Part III of a three-part article, the authors examine various degradation routes of APIs, impurities arising from interactions in formulations, metabolite impurities, various analytical methods to measure impuritie, and ways to control impurities. Apr 2, 2012By: Kashyap R. Wadekar,?Ponnaiah Ravi,?Mitali Bhalme,?S. Srinivasa Rao,?K. Vigneshwar Reddy,?L. Sampath Kumar,?E. BalasubrahmanyamPharmaceutical TechnologyVolume 36, Issue 4, pp. 76-86  Controlling and monitoring impurities in APIs and finished drug products is a crucial issue in